Live Breaking News & Updates on Davidl Epstein|Page 1

Stay updated with breaking news from Davidl epstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aerie Pharma (AERI) Gets a Buy Rating from Needham


Markets
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a price target of $26.00. The company’s shares closed last Tuesday at $17.66.
According to TipRanks.com, Belanger is a 4-star analyst with an average return of 8.8% and a 49.5% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, KalVista Pharmaceuticals, and Collegium Pharmaceutical.
Aerie Pharma has an analyst consensus of Strong Buy, with a price target consensus of $27.25, implying a 47.6% upside from current levels. In a report issued on April 15, Oppenheimer also maintained a Buy rating on the stock with a $26.00 price target. ....

Serge Belanger , Caseyc Kopczynski , Davidl Epstein , Ericj Toone , Amphastar Pharmaceuticals , Aerie Pharmaceuticals Inc , Kalvista Pharmaceuticals , Aerie Pharma , Research Report , Strong Buy , செர்ஜ் பேலங்கேர் , ஏறியே மருந்துகள் இன்க் , ஏறியே பார்மா , ஆராய்ச்சி அறிக்கை , வலுவான வாங்க ,